BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Eye Cancer Patient Treated Using Varian’s New HyperArc High Definition Radiotherapy Technology

  A 71-year-old eye cancer patient has become the first person in the UK, and among the first in the world, to be treated using HyperArc HDRT technology from Varian Medical Systems.

  October 23, 2017

   · 

  2 min read
• Genetown

  Publication in npj Vaccines Demonstrates CureVac’s RNActive Vaccine is Superior to Licensed Vaccines

  CureVac today announced the publication of a study in the peer-reviewed journal, Nature Partner Journals Vaccines, demonstrating that vaccines based on CureVac’s sequence optimized, chemically unmodified mRNA formulated in optimized LNPs are highly immunogenic and well tolerated.

  October 23, 2017

   · 

  3 min read
• Business

  Agenus Creates New Cell Therapy Subsidiary Named AgenTus Therapeutics

  Agenus today announced the launch of a subsidiary company for its cell therapy business, AgenTus Therapeutics.

  October 23, 2017

   · 

  5 min read
• Pilgrim Quality Solutions to Address Pharmaceutical Implications of CDER Metrics and Reporting

  Pilgrim Quality Solutions announced it will present a live webcast later this month for pharmaceutical organizations on the implications of participating in the FDA Quality Metrics reporting program.

  October 23, 2017

   · 

  2 min read
• Business

  Clovis Oncology to Announce Third Quarter 2017 Financial Results and Host Webcast Conference Call on November 1

  Clovis Oncology, Inc. will announce its third quarter 2017 financial results on Wednesday, November 1, 2017, after the close of the U.S. financial markets.

  October 23, 2017

   · 

  1 min read
• BioMidwest

  Surmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil Drug-Coated Balloon

  Surmodics, Inc. today announced enrollment of the first patient in TRANSCEND, the pivotal clinical trial for the SurVeil drug-coated balloon (DCB).

  October 23, 2017

   · 

  5 min read
• Genetown

  NinePoint Medical Release: New Clinical Data Presented At the World Congress of Gastroenterology At ACG 2017 Shows Increased Dysplasia Detection Using Volumetric Laser Endomicroscopy With Laser Marking

  NinePoint Medical announced exciting new clinical data which was presented at the Plenary session at the World Congress of Gastroenterology at the ACG 2017 in Orlando, FL.

  October 23, 2017

   · 

  4 min read
• Drug Development

  W. L. Gore & Associates, Inc. Release: Physicians Report Early Successes Across Multiple Applications in First-in-Human Uses of GORE® SYNECOR Preperitoneal Biomaterial Hernia Repair Device

  Physicians among the first to use the GORE SYNECOR Preperitoneal Biomaterial, a unique hybrid device for hernia repair, are reporting positive experiences in using the device in a range of applications, according to W. L. Gore & Associates (Gore).

  October 23, 2017

   · 

  5 min read
• 

  Biotech Bay

  Bay Area’s Claret Medical Nabs $14.5M

  The investment was led by Lightstone Ventures, with participation from existing investors Easton Capital, HealthCor Partners, Incept LLC and Sante Ventures.

  October 23, 2017

   · 

  3 min read
• Biotech Beach

  Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting 2017

  Arrowhead Pharmaceuticals today presented data from studies demonstrating promising preclinical safety and efficacy of ARO-AAT.

  October 23, 2017

   · 

  4 min read